About
- About
- Contact Us
Pipeline
Science
- Science
- DKK1
- DKN-01
- Claudin18.2
- GDF15
Patients
- Patients
- Expanded access
Careers
Investors

Anti-CLDN18.2
programs

FL-301 (NBL-015)Anti-CLDN18.2 antibody

Gastric
Pancreatic

FL-302 (NBL-016) Anti-CLDN18.2/CD137 antibody

47 Thorndike Street, Suite B1-1 Cambridge, MA 02141 USA

+1 617 714 0360

Business inquiries
bd@leaptx.com

Investor inquiries
ir@leaptx.com

About
Contact Us

Careers

Pipeline
DKN-01 Programs
Anti-CLDN18.2 Programs
FL-501

Patients
Expanded access

Science
DKK1
DKN-01
Claudin18.2
GDF15

Investors
Stock Information
News Releases
Presentations & Events
Financial Information
Corporate Governance
Information Request

© 2024 Leap Therapeutics, Inc.
All Rights Reserved.

Terms of Use
Privacy Policy
Cookie Policy

You are now leaving leaptx.com

We are not responsible for the content, views, or privacy policies of this third-party site